BioDuro & neoX Partner to Create Next Generation Antibody Discovery Platform

SAN DIEGO & BEIJING–(BUSINESS WIRE)–BioDuro, LLC, a leading drug discovery and development services organization, and neoX, a leading-edge artificial intelligence and biophysics focused biotech, announced today a strategic cooperation to establish the first antibody discovery platform to combine artificial intelligence (AI) and synthetic antibody discovery. The combined platform will enable the companies? biopharma partners to shorten timelines and improve quality of antibody-based drug devel